Filip Smit1, Linda Bolier, Pim Cuijpers. 1. Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands. fsmit@trimbos.nl
Abstract
AIM: To study the role of cannabis use in the onset of symptoms and disorders in the schizophrenia spectrum. DESIGN: Review of five population-based, longitudinal studies on the relationship between cannabis use and problems ranging from the experience of psychotic symptoms to hospitalization with a confirmed diagnosis of schizophrenia. Several hypotheses are examined that may explain this relationship: (1) self-medication; (2) effects of other drugs; (3) confounding; (4) stronger effect in predisposed people, and (5) etiological hypothesis. FINDINGS: Hypotheses 1 and 2 can be dismissed; hypothesis 3 is still open to debate, and converging evidence is found for hypotheses 4 and 5-antecedent cannabis use appears to act as a risk factor in the onset of schizophrenia, especially in vulnerable people, but also in people without prior history. CONCLUSION: There is an intrinsic message here for public health, but how that message is to be translated into action is not immediately clear.
AIM: To study the role of cannabis use in the onset of symptoms and disorders in the schizophrenia spectrum. DESIGN: Review of five population-based, longitudinal studies on the relationship between cannabis use and problems ranging from the experience of psychotic symptoms to hospitalization with a confirmed diagnosis of schizophrenia. Several hypotheses are examined that may explain this relationship: (1) self-medication; (2) effects of other drugs; (3) confounding; (4) stronger effect in predisposed people, and (5) etiological hypothesis. FINDINGS: Hypotheses 1 and 2 can be dismissed; hypothesis 3 is still open to debate, and converging evidence is found for hypotheses 4 and 5-antecedent cannabis use appears to act as a risk factor in the onset of schizophrenia, especially in vulnerable people, but also in people without prior history. CONCLUSION: There is an intrinsic message here for public health, but how that message is to be translated into action is not immediately clear.
Authors: Ron de Graaf; Mirjana Radovanovic; Margriet van Laar; Brian Fairman; Louisa Degenhardt; Sergio Aguilar-Gaxiola; Ronny Bruffaerts; Giovanni de Girolamo; John Fayyad; Oye Gureje; Josep Maria Haro; Yueqin Huang; Stanislav Kostychenko; Jean-Pierre Lépine; Herbert Matschinger; Maria Elena Medina Mora; Yehuda Neumark; Johan Ormel; Jose Posada-Villa; Dan J Stein; Hisateru Tachimori; J Elisabeth Wells; James C Anthony Journal: Am J Epidemiol Date: 2010-06-09 Impact factor: 4.897
Authors: Stefan G Kertesz; Mark J Pletcher; Monika Safford; Jewell Halanych; Katharine Kirk; Joseph Schumacher; Stephen Sidney; Catarina I Kiefe Journal: Drug Alcohol Depend Date: 2006-11-29 Impact factor: 4.492
Authors: Mason M Silveira; Jonathon C Arnold; Steven R Laviolette; Cecilia J Hillard; Marta Celorrio; María S Aymerich; Wendy K Adams Journal: Neurosci Biobehav Rev Date: 2016-09-14 Impact factor: 8.989
Authors: Luca Pauselli; Michael L Birnbaum; Beatriz Paulina Vázquez Jaime; Enrico Paolini; Mary E Kelley; Beth Broussard; Michael T Compton Journal: Schizophr Res Date: 2018-02-04 Impact factor: 4.939